Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [(18)F]FDG PET.

Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [(18)F]FDG PET.
复制标题

DOI:
10.1007/s11307-017-1136-0
复制
发表时间:
2018-06
影响因子:
3.1
通讯作者:
Guo Q
Guo Q
中科院分区:
医学3区
文献类型:
--
作者:
Sun H;Xin J;Zhou J;Lu Z;Guo Q

文献摘要

参考文献

被引文献

相似文献

采用脑PET/MRI混合成像技术,评估酰胺质子转移(APT)成像与钆增强磁共振成像(MRI)和2-脱氧-2-[18F-]氟-d -葡萄糖([18F]FDG)正电子发射断层扫描(PET)的诊断一致性和计量相关性。21例受试者接受脑钆增强[18F]FDG PET/MRI前瞻性检查。根据6项诊断标准,比较未增强MRI、增强MRI、APTW和PET的成像准确性。在肿瘤中,进一步采用McNemar试验评估钆增强成像、APT成像与[18F]FDG PET的一致性。通过Pearson相关分析,分析APT成像与PET指标之间的关系。APT成像和钆增强MRI显示出优越且相似的诊断准确性。APTW信号强度与钆增强在19例(100%)中一致,而高[18F]FDG密度仅在12例(63.2%)中显示。在APT成像与PET指标方面,13例高代谢肿瘤与PET指标有显著相关性(P < 0.05),其余6例FDG-avid肿瘤与APT成像指标无相关性[18F]。APT成像可用于提高诊断准确性,无需使用钆螯合物。在脑PET/MR研究中,APT成像可能为[18F]FDG PET评估肿瘤代谢活性提供附加价值。
To evaluate the diagnostic concordance and metric correlations of amide proton transfer (APT) imaging with gadolinium-enhanced magnetic resonance imaging (MRI) and 2-deoxy-2-[18F-]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET), using hybrid brain PET/MRI. Twenty-one subjects underwent brain gadolinium enhanced [18F]FDG PET/MRI prospectively. Imaging accuracy was compared between unenhanced MRI, MRI with enhancement, APT-weighted (APTW) images, and PET based on six diagnostic criteria. Among tumors, the McNemar test was further used for concordance assessment between gadolinium enhanced imaging, APT imaging, and [18F]FDG PET. As well, the relation of metrics between APT imaging and PET was analyzed by the Pearson correlation analysis. APT imaging and gadolinium-enhanced MRI showed superior and similar diagnostic accuracy. APTW signal intensity and gadolinium enhancement were concordant in 19 tumors (100%), while high [18F]FDG avidity was shown in only 12 (63.2%). For the metrics from APT imaging and PET, there was significant correlation for 13 hypermetabolic tumors (P < 0.05) and no correlation for the remaining six [18F]FDG-avid tumors. APT imaging can be used to increase diagnostic accuracy with no need to administer gadolinium chelates. APT imaging may provide an added value to [18F]FDG PET in the evaluation of tumor metabolic activity during brain PET/MR studies.
使用内源性蛋白质和肽的分子磁共振成像区分神经胶质瘤和放射性坏死
DOI: 10.1038/nm.2268
发表时间: 2011-01
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1007/s12149-015-1050-y
发表时间: 2016-04-01
影响因子: 2.6
作者:
Ishii, Shirou;Shimao, Daisuke;Shishido, Fumio
通讯作者: Shishido, Fumio
DOI: 10.1007/s00259-013-2668-4
发表时间: 2014-05-01
影响因子: 9.1
作者:
Sun, Hongzan;Xin, Jun;Wang, Baijun
通讯作者: Wang, Baijun
DOI: 10.1093/brain/awu374
发表时间: 2015-01
期刊: Brain : a journal of neurology
影响因子: --
作者:
Harston GW;Tee YK;Blockley N;Okell TW;Thandeswaran S;Shaya G;Sheerin F;Cellerini M;Payne S;Jezzard P;Chappell M;Kennedy J
通讯作者: Kennedy J
DOI: 10.2967/jnumed.113.131516
发表时间: 2015-10
期刊: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子: --
作者:
Fink JR;Muzi M;Peck M;Krohn KA
通讯作者: Krohn KA